Skip to main content
Clinical Trials/IRCT20160524028038N16
IRCT20160524028038N16
Recruiting
Phase 3

Evaluation of the effect of sildenafil along with metformin on the sexual function of patients with polycystic ovary syndrome treated with metformin.

Bandare-abbas University of Medical Sciences0 sites108 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Bandare-abbas University of Medical Sciences
Enrollment
108
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Bandare-abbas University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 to 45 years
  • Body mass index 19\-25
  • Confirmation of polycystic ovary syndrome based on the Rotterdam criteria

Exclusion Criteria

  • Patients who do not want to cooperate.
  • Sildenafil sensitivity and intolerance to side effects (hot flashes, vision disorders, severe drop in blood pressure and hearing disorders)
  • Taking ocp or ovulation stimulation drugs
  • Existence of severe mental conditions since 6 months before the research, which has an adverse effect on the patient's quality of life
  • Suffering from a severe degree of depression and anxiety according to the depression and anxiety questionnaire based on the Beck depression and anxiety questionnaire
  • Current use of psychiatric medications
  • Language or cognitive problems preventing the patient from completing the questionnaire
  • Current use of drugs affecting sexual performance
  • Previous diagnosis of an organic cause for sexual dysfunction by an experienced physician
  • Taking vasodilator drugs and drugs that interact with metformin, silde.

Outcomes

Primary Outcomes

Not specified

Similar Trials